SBIR/STTR Research Award
SBIR PHASE I - AUTOMATED NALOXONE DELIVERY SYSTEM. OTHER FUNCTIONS
Award amount
$149,171Program and phase
SBIR · Phase IAward year
2012Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CREARE LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- JDKYAKDT4TT6
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
The objective of the Phase I project is to prove the feasibility of the Automated Naloxone Delivery System (ANDS) by: (1) designing the physiological monitoring and prediction algorithm used to trigger the injection; (2) designing and developing prototypesof the automated naloxone injection system; (3) conducting structured interviews with potential users (opiate injectors and physicians) to determine the best automated naloxone dosing system design; and (4) designing the system to be fabricated and testing during the potential Phase II.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Improving Signal-to-Noise in Military Boom-Mounted Microphones
- A Defect and Damage Inspection Tool for Incoming Part Inspection
- Data Processing and Analysis Framework for Infrastructure Planning to Promote Active Transport
- Portable Hydrogen Filling System for Expeditionary Advanced Bases
- Low-Cost Closed-Loop Cryogenic Cooler for High Power Optics
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
1,365 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $507,020,394. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, Department of Energy, Department of Transportation, Department of Commerce